首页
>>
产品中心
>>
蛋白产品
>>
细菌蛋白
>
Inactivated Pneumococcal Type 14 Antigen

Inactivated Pneumococcal Type 14 Antigen

产品编号

BAG1120

别名

灭活14型肺炎球菌抗原,灭活肺炎球菌抗原, 肺炎球菌, Inactivated Pneumococcal Type 14, Pneumococcal

规格
  • 250ul
  • 1ml
产品介绍
Catalog NumberBAG1120
Alias灭活14型肺炎球菌抗原,灭活肺炎球菌抗原, 肺炎球菌, Inactivated Pneumococcal Type 14, Pneumococcal
Size250ul, 1ml
Molecular NamePneumococcal
Expression SystemPneumococcal
SpeciesBacteria
Purity>95%
PurificationIEC & HPLC
Storage ConditionStore the lyophilized powder at 4℃ for 6 months. It is recommended to aliquote to ~10ul per vial and store at -20℃ for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPowder or 0.1M PBS, PH 7.0
BackgroundThe symptoms of pneumococcal pneumonia can occur suddenly, typically presenting as a severe chill, later including a severe fever, cough, shortness of breath, rapid breathing, and chest pains. Other symptoms like nausea, vomiting, headache, fatigue, and muscle aches could also accompany the original symptoms. Sometimes the coughing can produce rusty or blood-streaked sputum. In 25% of cases, a parapneumonic effusion may occur. Chest X-rays will typically show lobar consolidation or patchy infiltrates.
ApplicationImmunogen, WB, ELISA
FAQ
  • CRM197是什么?它在肺炎球菌疫苗中扮演什么角色?

    CRM197 是一种无毒的白喉毒素突变体蛋白。它本身没有毒性,但保留了极强的免疫原性。在肺炎球菌结合疫苗中,它的角色是 “蛋白质载体” 。 核心作用: 肺炎球菌的荚膜多糖(针对不同血清型,如4型、6B型、19F型等)属于T细胞非依赖性抗原。单独接种时,它们在婴幼儿体内只能引起较弱的免疫反应,且不能产生免疫记忆。通过化学方法将这些多糖共价结合到CRM197载体蛋白上,就将疫苗变成了 “T细胞依赖性抗原” 。这使得婴幼儿的免疫系统能够被有效激活,产生更强、更持久的保护性抗体,并形成免疫记忆。

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价